| Accession |
PRJCA018179 |
| Title |
To investigate the safety, tolerability, pharmacokinetics and efficacy of SHR-A1904 (102) for injection in patients with advanced pancreatic cancer |
| Relevance |
Medical |
| Data types |
clinical,image,Metabolic,Biomarker,Genetic data
|
| Organisms |
Homo sapiens
|
| Description |
The safety, tolerability, pharmacokinetics and efficacy of SHR-A1904 for injection in patients with advanced pancreatic cancer were evaluated in an open-label, single-arm, multi-center phase I clinical trial |
| Sample scope |
Multiisolate |
| Release date |
2023-07-07 |
| Grants |
| Agency |
program |
Grant ID |
Grant title |
| NA
|
|
NA
|
|
|
|
| Submitter |
wanqiu
liang (wanqiu.liang@hengrui.com)
|
| Organization |
Jiangsu Hengrui Pharmaceutical Co. LTD |
| Submission date |
2023-07-07 |
